REVANESSE

Serial Number 88293145
Registration 6066727
700

Registration Progress

Application Filed
Feb 7, 2019
Under Examination
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered
Jun 2, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due: Jun 02, 2026 302 days

Trademark Image

REVANESSE

Basic Information

Serial Number
88293145
Registration Number
6066727
Filing Date
February 7, 2019
Registration Date
June 2, 2020
Published for Opposition
March 17, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 2, 2020
Registration
Registered
Classes
005

Rights Holder

Prollenium Medical Technologies, Inc.

03
Address
138 Industrial Parkway North
Aurora, Ontario L4G4C3
CA

Ownership History

Prollenium Medical Technologies, Inc.

Original Applicant
03
Aurora, Ontario CA

Prollenium Medical Technologies, Inc.

Owner at Publication
03
Aurora, Ontario CA

Prollenium Medical Technologies, Inc.

Original Registrant
03
Aurora, Ontario CA

Legal Representation

Attorney
Mark G. Kachigian

USPTO Deadlines

Next Deadline
302 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Jun 2, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 24, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 2, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 10, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 10, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 10, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 10, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 17, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 13, 2020 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jan 13, 2020 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jan 13, 2020 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Dec 18, 2019 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Dec 13, 2019 ALIE A ASSIGNED TO LIE Loading...
May 13, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 13, 2019 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
May 13, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 8, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 7, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 7, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 2, 2019 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
May 2, 2019 GPRA F PRIORITY ACTION E-MAILED Loading...
May 2, 2019 CPRA R PRIORITY ACTION WRITTEN Loading...
Apr 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 1, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Syringes containing hyaluronic acid gel for use in cosmetic treatment procedures and wound healing

Additional Information

Design Mark
The mark consists of the word "REVANESSE" in stylized font.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005